Instead of eliminating the virus, New Zealand will now focus on controlling it
Since the worldwide outbreak of Covid-19, New Zealand has drawn international attention for their successful policies on preventing the spread of the coronavirus.
On 17 August 2021, New Zealand went into lockdown after a Delta case was detected. This was the first case in the country after six months of zero cases. “For this outbreak, it’s clear that long periods of heavy restrictions has not got us to zero cases,” said Ardern, heading towards a change in New Zealand’s strict coronavirus elimination policies.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
New Zealand Gives Up On ‘Zero Covid’ Strategy Amid Persistent Delta Variant OutbreakAcknowledging the delta variant as a “game-changer,” New Zealand Prime Minister Jacinda Ardern said it could not be eliminated even with long-term restrictions.
Les mer »
An Unpredictable COVID-19 Situation Creates New Challenges for Race Directors This FallRegistration numbers are low, while emotions are running high.
Les mer »
New Zealand drops 'Covid zero' goal after Delta outbreakPrime Minister Jacinda Ardern admitted Monday that New Zealand's widely praised 'Covid zero' strategy had failed to halt a stubborn outbreak in Auckland and said a new approach was needed.
Les mer »
Fauci says new pill 'impressive' at keeping COVID patients alive and out of hospitalsA new pill to treat COVID-19 has shown “impressive” results in clinical trials, Dr. Anthony Fauci said during a Friday briefing of the White House pandemic response team. The drug, molnupiravir, is an antiviral treatment developed by Merck in conjunction with Ridgeback Biotherapeutics.
Les mer »
As Vaccination Numbers Continue to Stall, a New COVID Antiviral Pill Might Be Coming SoonThe oral antiviral from Merch and Ridgeback Biotherapeutics can reduce the risk of death and hospitalization by as much as 50 percent, its makers say.
Les mer »
Japan stocks set to rise after Merck announces new Covid treatment; China markets closedMerck and Ridgeback Biotherapeutics announced Friday they’ve developed a drug which reduces the risk of hospitalization or death by around 50% in Covid patients.
Les mer »